世界のDNA診断/検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global DNA Diagnostics/Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4145 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、DNA診断/検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCRベース診断、NGS DNA診断、in-situハイブリダイゼーション診断、マイクロアレイベース診断）、用途別市場規模（腫瘍学診断＆組織病理学、同一性診断＆法医学、薬理ゲノミクス診断試験＆薬物代謝）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・DNA診断/検査の市場動向 ・企業の競争状況、市場シェア ・DNA診断/検査の種類別市場規模と予測2016-2027（PCRベース診断、NGS DNA診断、in-situハイブリダイゼーション診断、マイクロアレイベース診断） ・DNA診断/検査の用途別市場規模と予測2016-2027（腫瘍学診断＆組織病理学、同一性診断＆法医学、薬理ゲノミクス診断試験＆薬物代謝） ・DNA診断/検査の北米市場規模2016-2027（アメリカ、カナダ） ・DNA診断/検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・DNA診断/検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・DNA診断/検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・DNA診断/検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Affymetrix Inc.、Agilent Technologies Inc、Applied Biosystems Group、Illumina Inc.、Cepheid Inc.、Hologic、Bio-Rad Laboratories、Dako、Abbott、Roche Diagnostics、Beckman Coulter Inc.、Siemens Healthcare） ・結論

Market Analysis and Insights: Global DNA Diagnostics/Testing Market
The global DNA Diagnostics/Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global DNA Diagnostics/Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global DNA Diagnostics/Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global DNA Diagnostics/Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global DNA Diagnostics/Testing market.

Global DNA Diagnostics/Testing Scope and Market Size
DNA Diagnostics/Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DNA Diagnostics/Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR Based Diagnostics
NGS DNA Diagnosis
In-situ Hybridization Diagnostics
Micro-arrays Based Diagnostics

Segment by Application
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Affymetrix Inc.
Agilent Technologies Inc
Applied Biosystems Group
Illumina Inc.
Cepheid Inc.
Hologic
Bio-Rad Laboratories
Dako
Abbott
Roche Diagnostics
Beckman Coulter Inc.
Siemens Healthcare

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA Diagnostics/Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR Based Diagnostics
1.2.3 NGS DNA Diagnosis
1.2.4 In-situ Hybridization Diagnostics
1.2.5 Micro-arrays Based Diagnostics
1.3 Market by Application
1.3.1 Global DNA Diagnostics/Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology Diagnostics & Histopathology
1.3.3 Identity Diagnostics & Forensics
1.3.4 Pharmacogenomics Diagnostic Testing & Drug Metabolism
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global DNA Diagnostics/Testing Market Perspective (2016-2027)
2.2 DNA Diagnostics/Testing Growth Trends by Regions
2.2.1 DNA Diagnostics/Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 DNA Diagnostics/Testing Historic Market Share by Regions (2016-2021)
2.2.3 DNA Diagnostics/Testing Forecasted Market Size by Regions (2022-2027)
2.3 DNA Diagnostics/Testing Industry Dynamic
2.3.1 DNA Diagnostics/Testing Market Trends
2.3.2 DNA Diagnostics/Testing Market Drivers
2.3.3 DNA Diagnostics/Testing Market Challenges
2.3.4 DNA Diagnostics/Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top DNA Diagnostics/Testing Players by Revenue
3.1.1 Global Top DNA Diagnostics/Testing Players by Revenue (2016-2021)
3.1.2 Global DNA Diagnostics/Testing Revenue Market Share by Players (2016-2021)
3.2 Global DNA Diagnostics/Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by DNA Diagnostics/Testing Revenue
3.4 Global DNA Diagnostics/Testing Market Concentration Ratio
3.4.1 Global DNA Diagnostics/Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA Diagnostics/Testing Revenue in 2020
3.5 DNA Diagnostics/Testing Key Players Head office and Area Served
3.6 Key Players DNA Diagnostics/Testing Product Solution and Service
3.7 Date of Enter into DNA Diagnostics/Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 DNA Diagnostics/Testing Breakdown Data by Type
4.1 Global DNA Diagnostics/Testing Historic Market Size by Type (2016-2021)
4.2 Global DNA Diagnostics/Testing Forecasted Market Size by Type (2022-2027)

5 DNA Diagnostics/Testing Breakdown Data by Application
5.1 Global DNA Diagnostics/Testing Historic Market Size by Application (2016-2021)
5.2 Global DNA Diagnostics/Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America DNA Diagnostics/Testing Market Size (2016-2027)
6.2 North America DNA Diagnostics/Testing Market Size by Type
6.2.1 North America DNA Diagnostics/Testing Market Size by Type (2016-2021)
6.2.2 North America DNA Diagnostics/Testing Market Size by Type (2022-2027)
6.2.3 North America DNA Diagnostics/Testing Market Size by Type (2016-2027)
6.3 North America DNA Diagnostics/Testing Market Size by Application
6.3.1 North America DNA Diagnostics/Testing Market Size by Application (2016-2021)
6.3.2 North America DNA Diagnostics/Testing Market Size by Application (2022-2027)
6.3.3 North America DNA Diagnostics/Testing Market Size by Application (2016-2027)
6.4 North America DNA Diagnostics/Testing Market Size by Country
6.4.1 North America DNA Diagnostics/Testing Market Size by Country (2016-2021)
6.4.2 North America DNA Diagnostics/Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe DNA Diagnostics/Testing Market Size (2016-2027)
7.2 Europe DNA Diagnostics/Testing Market Size by Type
7.2.1 Europe DNA Diagnostics/Testing Market Size by Type (2016-2021)
7.2.2 Europe DNA Diagnostics/Testing Market Size by Type (2022-2027)
7.2.3 Europe DNA Diagnostics/Testing Market Size by Type (2016-2027)
7.3 Europe DNA Diagnostics/Testing Market Size by Application
7.3.1 Europe DNA Diagnostics/Testing Market Size by Application (2016-2021)
7.3.2 Europe DNA Diagnostics/Testing Market Size by Application (2022-2027)
7.3.3 Europe DNA Diagnostics/Testing Market Size by Application (2016-2027)
7.4 Europe DNA Diagnostics/Testing Market Size by Country
7.4.1 Europe DNA Diagnostics/Testing Market Size by Country (2016-2021)
7.4.2 Europe DNA Diagnostics/Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific DNA Diagnostics/Testing Market Size (2016-2027)
8.2 Asia-Pacific DNA Diagnostics/Testing Market Size by Type
8.2.1 Asia-Pacific DNA Diagnostics/Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific DNA Diagnostics/Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific DNA Diagnostics/Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific DNA Diagnostics/Testing Market Size by Application
8.3.1 Asia-Pacific DNA Diagnostics/Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific DNA Diagnostics/Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific DNA Diagnostics/Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific DNA Diagnostics/Testing Market Size by Region
8.4.1 Asia-Pacific DNA Diagnostics/Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific DNA Diagnostics/Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America DNA Diagnostics/Testing Market Size (2016-2027)
9.2 Latin America DNA Diagnostics/Testing Market Size by Type
9.2.1 Latin America DNA Diagnostics/Testing Market Size by Type (2016-2021)
9.2.2 Latin America DNA Diagnostics/Testing Market Size by Type (2022-2027)
9.2.3 Latin America DNA Diagnostics/Testing Market Size by Type (2016-2027)
9.3 Latin America DNA Diagnostics/Testing Market Size by Application
9.3.1 Latin America DNA Diagnostics/Testing Market Size by Application (2016-2021)
9.3.2 Latin America DNA Diagnostics/Testing Market Size by Application (2022-2027)
9.3.3 Latin America DNA Diagnostics/Testing Market Size by Application (2016-2027)
9.4 Latin America DNA Diagnostics/Testing Market Size by Country
9.4.1 Latin America DNA Diagnostics/Testing Market Size by Country (2016-2021)
9.4.2 Latin America DNA Diagnostics/Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa DNA Diagnostics/Testing Market Size (2016-2027)
10.2 Middle East & Africa DNA Diagnostics/Testing Market Size by Type
10.2.1 Middle East & Africa DNA Diagnostics/Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa DNA Diagnostics/Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa DNA Diagnostics/Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa DNA Diagnostics/Testing Market Size by Application
10.3.1 Middle East & Africa DNA Diagnostics/Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa DNA Diagnostics/Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa DNA Diagnostics/Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa DNA Diagnostics/Testing Market Size by Country
10.4.1 Middle East & Africa DNA Diagnostics/Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa DNA Diagnostics/Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories DNA Diagnostics/Testing Introduction
11.1.4 Abbott Laboratories Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Affymetrix Inc.
11.2.1 Affymetrix Inc. Company Details
11.2.2 Affymetrix Inc. Business Overview
11.2.3 Affymetrix Inc. DNA Diagnostics/Testing Introduction
11.2.4 Affymetrix Inc. Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.2.5 Affymetrix Inc. Recent Development
11.3 Agilent Technologies Inc
11.3.1 Agilent Technologies Inc Company Details
11.3.2 Agilent Technologies Inc Business Overview
11.3.3 Agilent Technologies Inc DNA Diagnostics/Testing Introduction
11.3.4 Agilent Technologies Inc Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.3.5 Agilent Technologies Inc Recent Development
11.4 Applied Biosystems Group
11.4.1 Applied Biosystems Group Company Details
11.4.2 Applied Biosystems Group Business Overview
11.4.3 Applied Biosystems Group DNA Diagnostics/Testing Introduction
11.4.4 Applied Biosystems Group Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.4.5 Applied Biosystems Group Recent Development
11.5 Illumina Inc.
11.5.1 Illumina Inc. Company Details
11.5.2 Illumina Inc. Business Overview
11.5.3 Illumina Inc. DNA Diagnostics/Testing Introduction
11.5.4 Illumina Inc. Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.5.5 Illumina Inc. Recent Development
11.6 Cepheid Inc.
11.6.1 Cepheid Inc. Company Details
11.6.2 Cepheid Inc. Business Overview
11.6.3 Cepheid Inc. DNA Diagnostics/Testing Introduction
11.6.4 Cepheid Inc. Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.6.5 Cepheid Inc. Recent Development
11.7 Hologic
11.7.1 Hologic Company Details
11.7.2 Hologic Business Overview
11.7.3 Hologic DNA Diagnostics/Testing Introduction
11.7.4 Hologic Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.7.5 Hologic Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories DNA Diagnostics/Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Dako
11.9.1 Dako Company Details
11.9.2 Dako Business Overview
11.9.3 Dako DNA Diagnostics/Testing Introduction
11.9.4 Dako Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.9.5 Dako Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott DNA Diagnostics/Testing Introduction
11.10.4 Abbott Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.10.5 Abbott Recent Development
11.11 Roche Diagnostics
11.11.1 Roche Diagnostics Company Details
11.11.2 Roche Diagnostics Business Overview
11.11.3 Roche Diagnostics DNA Diagnostics/Testing Introduction
11.11.4 Roche Diagnostics Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.11.5 Roche Diagnostics Recent Development
11.12 Beckman Coulter Inc.
11.12.1 Beckman Coulter Inc. Company Details
11.12.2 Beckman Coulter Inc. Business Overview
11.12.3 Beckman Coulter Inc. DNA Diagnostics/Testing Introduction
11.12.4 Beckman Coulter Inc. Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.12.5 Beckman Coulter Inc. Recent Development
11.13 Siemens Healthcare
11.13.1 Siemens Healthcare Company Details
11.13.2 Siemens Healthcare Business Overview
11.13.3 Siemens Healthcare DNA Diagnostics/Testing Introduction
11.13.4 Siemens Healthcare Revenue in DNA Diagnostics/Testing Business (2016-2021)
11.13.5 Siemens Healthcare Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global DNA Diagnostics/Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR Based Diagnostics
Table 3. Key Players of NGS DNA Diagnosis
Table 4. Key Players of In-situ Hybridization Diagnostics
Table 5. Key Players of Micro-arrays Based Diagnostics
Table 6. Global DNA Diagnostics/Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global DNA Diagnostics/Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global DNA Diagnostics/Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global DNA Diagnostics/Testing Market Share by Regions (2016-2021)
Table 10. Global DNA Diagnostics/Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global DNA Diagnostics/Testing Market Share by Regions (2022-2027)
Table 12. DNA Diagnostics/Testing Market Trends
Table 13. DNA Diagnostics/Testing Market Drivers
Table 14. DNA Diagnostics/Testing Market Challenges
Table 15. DNA Diagnostics/Testing Market Restraints
Table 16. Global DNA Diagnostics/Testing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global DNA Diagnostics/Testing Market Share by Players (2016-2021)
Table 18. Global Top DNA Diagnostics/Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Diagnostics/Testing as of 2020)
Table 19. Ranking of Global Top DNA Diagnostics/Testing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by DNA Diagnostics/Testing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players DNA Diagnostics/Testing Product Solution and Service
Table 23. Date of Enter into DNA Diagnostics/Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global DNA Diagnostics/Testing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global DNA Diagnostics/Testing Revenue Market Share by Type (2016-2021)
Table 27. Global DNA Diagnostics/Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global DNA Diagnostics/Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global DNA Diagnostics/Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global DNA Diagnostics/Testing Revenue Market Share by Application (2016-2021)
Table 31. Global DNA Diagnostics/Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global DNA Diagnostics/Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America DNA Diagnostics/Testing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America DNA Diagnostics/Testing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America DNA Diagnostics/Testing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America DNA Diagnostics/Testing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America DNA Diagnostics/Testing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America DNA Diagnostics/Testing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe DNA Diagnostics/Testing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe DNA Diagnostics/Testing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe DNA Diagnostics/Testing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe DNA Diagnostics/Testing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe DNA Diagnostics/Testing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe DNA Diagnostics/Testing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific DNA Diagnostics/Testing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific DNA Diagnostics/Testing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific DNA Diagnostics/Testing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific DNA Diagnostics/Testing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific DNA Diagnostics/Testing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific DNA Diagnostics/Testing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America DNA Diagnostics/Testing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America DNA Diagnostics/Testing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America DNA Diagnostics/Testing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America DNA Diagnostics/Testing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America DNA Diagnostics/Testing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America DNA Diagnostics/Testing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa DNA Diagnostics/Testing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa DNA Diagnostics/Testing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa DNA Diagnostics/Testing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa DNA Diagnostics/Testing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa DNA Diagnostics/Testing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa DNA Diagnostics/Testing Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories DNA Diagnostics/Testing Product
Table 66. Abbott Laboratories Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 67. Abbott Laboratories Recent Development
Table 68. Affymetrix Inc. Company Details
Table 69. Affymetrix Inc. Business Overview
Table 70. Affymetrix Inc. DNA Diagnostics/Testing Product
Table 71. Affymetrix Inc. Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 72. Affymetrix Inc. Recent Development
Table 73. Agilent Technologies Inc Company Details
Table 74. Agilent Technologies Inc Business Overview
Table 75. Agilent Technologies Inc DNA Diagnostics/Testing Product
Table 76. Agilent Technologies Inc Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 77. Agilent Technologies Inc Recent Development
Table 78. Applied Biosystems Group Company Details
Table 79. Applied Biosystems Group Business Overview
Table 80. Applied Biosystems Group DNA Diagnostics/Testing Product
Table 81. Applied Biosystems Group Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 82. Applied Biosystems Group Recent Development
Table 83. Illumina Inc. Company Details
Table 84. Illumina Inc. Business Overview
Table 85. Illumina Inc. DNA Diagnostics/Testing Product
Table 86. Illumina Inc. Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 87. Illumina Inc. Recent Development
Table 88. Cepheid Inc. Company Details
Table 89. Cepheid Inc. Business Overview
Table 90. Cepheid Inc. DNA Diagnostics/Testing Product
Table 91. Cepheid Inc. Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 92. Cepheid Inc. Recent Development
Table 93. Hologic Company Details
Table 94. Hologic Business Overview
Table 95. Hologic DNA Diagnostics/Testing Product
Table 96. Hologic Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 97. Hologic Recent Development
Table 98. Bio-Rad Laboratories Company Details
Table 99. Bio-Rad Laboratories Business Overview
Table 100. Bio-Rad Laboratories Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 101. Bio-Rad Laboratories Recent Development
Table 102. Dako Company Details
Table 103. Dako Business Overview
Table 104. Dako DNA Diagnostics/Testing Product
Table 105. Dako Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 106. Dako Recent Development
Table 107. Abbott Company Details
Table 108. Abbott Business Overview
Table 109. Abbott DNA Diagnostics/Testing Product
Table 110. Abbott Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 111. Abbott Recent Development
Table 112. Roche Diagnostics Company Details
Table 113. Roche Diagnostics Business Overview
Table 114. Roche Diagnostics DNA Diagnostics/Testing Product
Table 115. Roche Diagnostics Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 116. Roche Diagnostics Recent Development
Table 117. Beckman Coulter Inc. Company Details
Table 118. Beckman Coulter Inc. Business Overview
Table 119. Beckman Coulter Inc. DNA Diagnostics/Testing Product
Table 120. Beckman Coulter Inc. Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 121. Beckman Coulter Inc. Recent Development
Table 122. Siemens Healthcare Company Details
Table 123. Siemens Healthcare Business Overview
Table 124. Siemens Healthcare DNA Diagnostics/Testing Product
Table 125. Siemens Healthcare Revenue in DNA Diagnostics/Testing Business (2016-2021) & (US$ Million)
Table 126. Siemens Healthcare Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global DNA Diagnostics/Testing Market Share by Type: 2020 VS 2027
Figure 2. PCR Based Diagnostics Features
Figure 3. NGS DNA Diagnosis Features
Figure 4. In-situ Hybridization Diagnostics Features
Figure 5. Micro-arrays Based Diagnostics Features
Figure 6. Global DNA Diagnostics/Testing Market Share by Application: 2020 VS 2027
Figure 7. Oncology Diagnostics & Histopathology Case Studies
Figure 8. Identity Diagnostics & Forensics Case Studies
Figure 9. Pharmacogenomics Diagnostic Testing & Drug Metabolism Case Studies
Figure 10. DNA Diagnostics/Testing Report Years Considered
Figure 11. Global DNA Diagnostics/Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global DNA Diagnostics/Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global DNA Diagnostics/Testing Market Share by Regions: 2020 VS 2027
Figure 14. Global DNA Diagnostics/Testing Market Share by Regions (2022-2027)
Figure 15. Global DNA Diagnostics/Testing Market Share by Players in 2020
Figure 16. Global Top DNA Diagnostics/Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Diagnostics/Testing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by DNA Diagnostics/Testing Revenue in 2020
Figure 18. Global DNA Diagnostics/Testing Revenue Market Share by Type (2016-2021)
Figure 19. Global DNA Diagnostics/Testing Revenue Market Share by Type (2022-2027)
Figure 20. North America DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America DNA Diagnostics/Testing Market Share by Type (2016-2027)
Figure 22. North America DNA Diagnostics/Testing Market Share by Application (2016-2027)
Figure 23. North America DNA Diagnostics/Testing Market Share by Country (2016-2027)
Figure 24. United States DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe DNA Diagnostics/Testing Market Share by Type (2016-2027)
Figure 28. Europe DNA Diagnostics/Testing Market Share by Application (2016-2027)
Figure 29. Europe DNA Diagnostics/Testing Market Share by Country (2016-2027)
Figure 30. Germany DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific DNA Diagnostics/Testing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific DNA Diagnostics/Testing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific DNA Diagnostics/Testing Market Share by Region (2016-2027)
Figure 40. China DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America DNA Diagnostics/Testing Market Share by Type (2016-2027)
Figure 48. Latin America DNA Diagnostics/Testing Market Share by Application (2016-2027)
Figure 49. Latin America DNA Diagnostics/Testing Market Share by Country (2016-2027)
Figure 50. Mexico DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa DNA Diagnostics/Testing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa DNA Diagnostics/Testing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa DNA Diagnostics/Testing Market Share by Country (2016-2027)
Figure 56. Turkey DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE DNA Diagnostics/Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Laboratories Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 60. Affymetrix Inc. Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 61. Agilent Technologies Inc Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 62. Applied Biosystems Group Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 63. Illumina Inc. Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 64. Cepheid Inc. Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 65. Hologic Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 66. Bio-Rad Laboratories Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 67. Dako Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 68. Abbott Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 69. Roche Diagnostics Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 70. Beckman Coulter Inc. Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 71. Siemens Healthcare Revenue Growth Rate in DNA Diagnostics/Testing Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---